GlassScriptPhysician profile
Isaac Alevi
NPI 1942398359
$1,315.46
in general payments reported to CMS, 2019-2025
11 companies · $148 in 2025
The $148 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2022: $293 · 2023: $553 · 2024: $74.32 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $407.71 | 2022-2023 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $135.00 | 2023 | Austedo |
| Progenics Pharmaceuticals, INC. | $125.00 | 2023 | Pylarify |
| Ascendis Pharma Endocrinology INC | $125.00 | 2025 | Yorvipath |
| Horizon Therapeutics Plc | $124.99 | 2019 | |
| Vifor Pharma, INC. | $121.95 | 2019 | |
| Intuity Medical INC | $111.11 | 2022 | |
| Alk-Abello, INC | $78.13 | 2024-2025 | Odactra, Grastek, Ragwitek |
| Cranial Technologies, INC | $37.35 | 2023-2024 | Doc Band |
| Phadia US INC. | $24.75 | 2023 | Immunocap |
| Global Blood Therapeutics, INC. | $24.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Alevi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.